CoChat
Sign Up
Cited by 52Bone health and osteoporosis researchOpioid Use Disorder TreatmentPain Management and Opioid Use

Opioid osteoporosis

Daniell, Harry W.·2004·Archives of Internal Medicine
DOI 10.1001/archinte.164.3.338-a
Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1001/archinte.164.3.338-a

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Among fentanyl-exposed patients, LAIB was superior to TMB for urine samples negative for fentanyl.

    “Both buprenorphine treatments were effective in reducing opioid withdrawal and cravings, but LAIB was superior to TMB for urine samples negative for fentanyl among patients who were fentanyl-exposed.12”

    From Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al. (2025) · cites this paper as [12]

  • Direct comparisons showing comparable outcomes for long-acting injectable buprenorphine relative to TMB suggest that LAIB may be a viable alternative for patients at high risk of oral health problems, including fentanyl-exposed patients who may need higher sublingual doses.

    “Direct comparisons showing comparable outcomes for long-acting injectable buprenorphine (LAIB) relative to TMB suggest LAIB may be a viable treatment alternative for patients at high risk for oral health problems, including patients exposed to fentanyl who may require higher sublingual doses.”

    From Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al. (2025) · cites this paper as [12]

  • Both LAIB and TMB were effective in reducing opioid withdrawal and cravings.

    “Both buprenorphine treatments were effective in reducing opioid withdrawal and cravings, but LAIB was superior to TMB for urine samples negative for fentanyl among patients who were fentanyl-exposed.12”

    From Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al. (2025) · cites this paper as [12]

  • Post hoc comparisons from a randomized controlled trial comparing LAIB with TMB showed notable but underpowered group differences favoring LAIB for urine samples negative for any opioid.

    “Post hoc comparisons from a randomized controlled trial comparing LAIB to TMB showed notable, but underpowered, group differences favoring the former for urine samples negative for any opioid.”

    From Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al. (2025) · cites this paper as [12]

  • Testosterone therapy may be justifiable in men receiving opioids who may suffer from opioid-induced suppression of testosterone levels and associated sexual dysfunction, osteoporosis, and/or muscle atrophy.

    “Testosterone therapy may be justifiable in patients with some of these conditions, such as men receiving opioids, who may suffer from opioid-induced suppression of testosterone levels 32 and sexual dysfunction, 33 osteoporosis, and/or muscle atrophy.34”

    From Who Gets Testosterone? Patient Characteristics Associated with Testosterone Prescribing in the Veteran Affairs System: a Cross-Sectional Study (2017) · cites this paper as [34]

Cites

Still being checked.

Cited by

Sorted by citations

Related

Authors
Daniell, H. W.
Venue
Archives of Internal Medicine
Publisher
American Medical Association (AMA)
Published
2004-02-09
Volume
164
Issue
3
Pages
338
ISSN
0003-9926 (ISSN-L)
DOI
10.1001/archinte.164.3.338-a
OpenAlex
W2811380478
Cited by
52
References
0
Citations by year
2025: 3 · 2024: 2 · 2023: 1 · 2021: 2 · 2020: 1 · 2019: 5 · 2018: 3 · 2017: 5 · 2016: 2 · 2015: 4 · 2014: 4 · 2013: 6 · 2012: 1
FWCI
1.63
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords
opioid analgesics, osteoporosis, bone loss, bone mineral density, drug-induced bone disease
MeSH terms
Analgesics, Opioid, Dose-Response Relationship, Drug, Female, Humans, Hypogonadism, Male, Opioid-Related Disorders, Osteoporosis, Bone Density, Muscle, Skeletal, Fractures, Bone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review